Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sexually Transmitted Diseases

Free Subscription Articles published in Cancer Retrieve available abstracts of 38 articles: HTML format

Single Articles

February 2023
1. CHERVEN B, Klosky JL, Keith KE, Hudson MM, et al
   Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.
   Cancer. 2023;129:614-623.
   PubMed     Abstract available
   
   
   
2. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
   Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
   Cancer. 2023;129:376-384.
   PubMed     Abstract available
   
   
   November 2022
3. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
   Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
   Cancer. 2022;128:3831-3842.
   PubMed     Abstract available
   
   
   October 2022
4. RIMEL BJ, Kunos CA, Macioce N, Temkin SM, et al
   Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
   Cancer. 2022 Oct 14. doi: 10.1002/cncr.34487.
   PubMed     Abstract available
   
   
   
5. MARKOVINA S, Rendle KA, Cohen AC, Kuroki LM, et al
   Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem.
   Cancer. 2022 Oct 14. doi: 10.1002/cncr.34485.
   PubMed     Abstract available
   
   
   June 2022
6. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
   Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
   Cancer. 2022;128:2193-2204.
   PubMed     Abstract available
   
   
   May 2022
7. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
   Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
   Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
   PubMed     Abstract available
   
   
   April 2022
8. O'ROURKE K
   Better HPV vaccination and cervical cancer screening needed.
   Cancer. 2022;128:1559.
   PubMed    
   
   
   February 2022
9. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
   Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
   Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
   PubMed     Abstract available
   
   
   
10. O'ROURKE K
    Cutaneous beta-HPV may predict cutaneous squamous cell carcinoma.
    Cancer. 2022;128:646.
    PubMed    
    
    
    
11. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    PubMed     Abstract available
    
    
    January 2022
12. HENDERSON TO, Fowler BW, Hamann HA, Nathan PC, et al
    Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Cancer. 2022;128:373-382.
    PubMed     Abstract available
    
    
    December 2021
13. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    PubMed    
    
    
    November 2021
14. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed     Abstract available
    
    
    October 2021
15. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    PubMed    
    
    
    
16. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    PubMed    
    
    
    
17. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available
    
    
    September 2021
18. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    PubMed     Abstract available
    
    
    
19. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    PubMed     Abstract available
    
    
    August 2021
20. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available
    
    
    July 2021
21. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed     Abstract available
    
    
    
22. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    PubMed     Abstract available
    
    
    June 2021
23. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    PubMed     Abstract available
    
    
    May 2021
24. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    PubMed     Abstract available
    
    
    April 2021
25. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    PubMed    
    
    
    
26. PRINTZ C
    Updated American Cancer Society HPV Vaccine Guideline Seeks to Reinforce Key Messages: New recommendations emphasize the importance of routinely offering the vaccine at the ages of 9 to 12 years.
    Cancer. 2021;127:1169-1170.
    PubMed    
    
    
    
27. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    PubMed     Abstract available
    
    
    March 2021
28. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available
    
    
    February 2021
29. SHEWALE JB, Pickard RKL, Xiao W, Jiang B, et al
    Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33440.
    PubMed     Abstract available
    
    
    
30. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    PubMed     Abstract available
    
    
    April 2020
31. BROTHERTON JML, Sundstrom K
    More evidence suggesting that 1-dose human papillomavirus vaccination may be effective.
    Cancer. 2020;126:1602-1604.
    PubMed    
    
    
    
32. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available
    
    
    
33. BIGELOW EO, Blackford AL, Eytan DF, Eisele DW, et al
    Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
    Cancer. 2020;126:1793-1803.
    PubMed     Abstract available
    
    
    
34. FULLERTON ZH, Butler SS, Mahal BA, Muralidhar V, et al
    Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Cancer. 2020;126:1424-1433.
    PubMed     Abstract available
    
    
    
35. OLIVER JR, Lieberman SM, Tam MM, Liu CZ, et al
    Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.
    Cancer. 2020;126:1413-1423.
    PubMed     Abstract available
    
    
    March 2020
36. ZHAN KY, Puram SV, Li MM, Silverman DA, et al
    National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1295-1305.
    PubMed     Abstract available
    
    
    January 2020
37. GAISA MM, Liu Y, Deshmukh AA, Stone KL, et al
    Electrocautery ablation of anal high-grade squamous intraepithelial lesions: Effectiveness and key factors associated with outcomes.
    Cancer. 2020 Jan 24. doi: 10.1002/cncr.32581.
    PubMed     Abstract available
    
    
    
38. FREITAG J, Wald T, Kuhnt T, Gradistanac T, et al
    Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1856-1872.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: